SHILPA GOLI

Allopathic & Osteopathic Physicians|Hospitalist JACKSONVILLE, FL NPI 1306084306

General Payments — all program years on this page

$1,565.19

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 88
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $392.34 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $392.3420

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $142.678
2019 $179.9912
2020 $205.0912
2021 $196.3813
2022 $193.4611
2023 $255.2612
2024 $392.3420

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077962398 Janssen Pharmaceuticals, Inc $21.87 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103813602 ABBVIE INC. $28.68 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104200153 AstraZeneca Pharmaceuticals LP $17.77 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104264405 AstraZeneca Pharmaceuticals LP $19.25 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105498560 AstraZeneca Pharmaceuticals LP $20.09 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131199914 PFIZER INC. $4.42 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131254027 PFIZER INC. $18.81 10/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131595826 PFIZER INC. $21.54 04/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131634559 PFIZER INC. $20.35 05/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131705321 PFIZER INC. $21.64 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131709983 PFIZER INC. $27.20 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131794025 PFIZER INC. $17.62 07/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131911012 PFIZER INC. $20.23 08/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131911014 PFIZER INC. $24.51 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132034944 PFIZER INC. $5.28 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132034946 PFIZER INC. $10.04 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132098227 PFIZER INC. $21.65 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141879199 Merck Sharp & Dohme LLC $20.10 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146960057 AIMMUNE THERAPEUTICS, INC. $20.90 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153658399 Salix Pharmaceuticals, a division of Bausch Health US, LLC $30.39 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.